Calendar Pliant Therapeutics, Inc.

Equities

PLRX

US7291391057

Market Closed - Nasdaq 04:00:00 2024-04-18 pm EDT 5-day change 1st Jan Change
12.19 USD -5.21% Intraday chart for Pliant Therapeutics, Inc. -15.76% -32.69%

Chart calendar Pliant Therapeutics, Inc.

b26e3.RIa4aGlGLs6mkoD88z3iV0tCfzN68t4ZZw0T92Z-zCc.PdaIWBp3XI3S-tHLlFaGAh4rD1kXhK51FVhnzj8MnlMW89UgWTd0l-PR2Q~7c8e64b9a2519982dd7e5c4b2d32aead

Upcoming events on Pliant Therapeutics, Inc.

2024-05-05 Q1 2024 Earnings Release (Projected)
2024-05-13 RBC Capital Markets Global Healthcare Conference
2024-05-19 02:30 pm American Thoracic Society Conference - Poster No:15055
2024-05-20 12:15 pm American Thoracic Society Conference - Poster No:11411
2024-05-21 12:15 pm American Thoracic Society Conference - Poster No:10368
2024-05-21 06:51 pm American Thoracic Society Conference - Oral Presentation No:10340
2024-08-04 Q2 2024 Earnings Release (Projected)
2024-11-04 Q3 2024 Earnings Release (Projected)
2025-03-03 Q4 2024 Earnings Release (Projected)

Past events on Pliant Therapeutics, Inc.

2024-04-16 Piper Sandler Spring Biopharma Symposium
2024-04-09 11:45 am Needham Healthcare Conference
2024-03-12 04:20 pm Leerink Partners Global Biopharma Conference
2024-03-05 12:50 pm TD Cowen Health Care Conference
2024-02-27 Wells Fargo West Coast Biotech Tour
2024-02-27 04:03 pm Q4 2023 Earnings Release
2024-02-13 12:00 pm Oppenheimer Healthcare Life Sciences Conference
2024-02-05 08:00 am INTEGRIS-PSC Phase 2a Trial Results Call
2024-01-09 10:30 am JPMorgan Healthcare Conference
2023-11-30 09:00 am Piper Sandler Healthcare Conference
2023-11-28 Evercore ISI HealthCONx Conference
2023-11-15 01:15 pm Stifel Healthcare Conference
2023-11-13 05:00 pm American Association for the Study of Liver Diseases Conference - Abstract #5008
2023-11-09 04:05 pm Q3 2023 Earnings Release
2023-11-04 12:00 pm Society for Immunotherapy of Cancer Meeting - Abstract No 464
2023-11-04 12:00 pm Society for Immunotherapy of Cancer Meeting - Abstract No: 714
2023-11-03 12:00 pm Society for Immunotherapy of Cancer Meeting - Abstract No: 1467
2023-09-28 11:30 am Cantor Global Healthcare Conference
2023-09-26 08:00 am INTEGRIS PSC Phase 2a Trial Results Call
2023-09-12 Baird Global Healthcare Conference

Annual results

Fiscal PeriodDecember 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
41,8
39,4
6.04%
7,57
7,72
-1.96%
9,69
8,99
7.71%
1,58
2,45
-35.43%

1,54

EBITDA
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
-125
-123
-2.28%
-182
-186
2.23%

-218

EBIT
Million USD
Released
Forecast
Spread
-41,6
-49,3
15.58%
-20,0
-101
80.12%
-127
-124
-2.92%
-184
-187
1.39%

-210

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-41,5
-61,0
31.91%
-19,7
-101
80.41%
-123
-122
-1.3%
-161
-170
5.34%

-203

Net income
Million USD
Released
Forecast
Spread
-41,5
-61,0
31.91%
-19,7
-101
80.41%
-123
-122
-1.25%
-161
-170
5.06%

-201

EPS
USD
Released
Forecast
Spread
-1,95
-2,90
32.76%
-2,71
-2,80
3.33%
-2,94
-2,89
-1.79%
-2,75
-2,91
5.34%

-3,29

Announcement Date16/03/2128/02/2209/03/2327/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
2,00
2,14
-6.71%
1,25
1,05
18.95%
4,99
1,20
315.79%
1,48
1,59
-6.98%
1,97
1,17
68.12%
1,33
0,88
50.82%
0,25
0,90
-72.36%
0,00
0,63
-
0,00
0,46
-

0,39


0,39


0,39


0,64


0,50

EBITDA
Million USD
Released
Forecast
Spread




























-50,0


-53,0


-58,0


-63,0




EBIT
Million USD
Released
Forecast
Spread
-24,6
-27,6
10.89%
-28,2
-27,6
-2.33%
-29,6
-29,5
-0.61%
-31,9
-33,7
5.19%
-37,4
-33,5
-11.52%
-42,1
-37,3
-12.79%
-47,3
-42,5
-11.38%
-47,7
-48,3
1.29%
-47,0
-50,1
6.14%

-49,1


-51,5


-53,9


-56,0


-61,1

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-24,5
-27,9
12.04%
-28,1
-27,6
-1.95%
-29,5
-29,6
0.16%
-30,6
-34,2
10.42%
-35,1
-33,5
-4.68%
-37,5
-36,7
-2.3%
-41,2
-41,1
-0.12%
-41,5
-47,6
12.86%
-41,1
-50,9
19.26%

-46,7


-49,7


-52,5


-54,9


-59,1

Net income
Million USD
Released
Forecast
Spread
-24,5
-27,9
12.01%
-28,1
-27,6
-1.9%
-29,5
-29,4
-0.5%
-30,6
-34,0
9.95%
-35,1
-33,5
-4.62%
-37,5
-36,9
-1.8%
-41,2
-41,3
0.32%
-41,5
-47,1
11.91%
-41,1
-50,2
18.17%

-46,5


-49,2


-51,8


-53,6


-59,1

EPS
USD
Released
Forecast
Spread
-0,68
-0,77
11.69%
-0,78
-0,75
-3.54%
-0,82
-0,81
-1.08%
-0,65
-0,74
12.16%
-0,72
-0,70
-3.17%
-0,67
-0,67
0%
-0,70
-0,71
1.73%
-0,70
-0,78
10.67%
-0,69
-0,82
16.11%

-0,77


-0,81


-0,85


-0,88


-0,85

Announcement Date28/02/2209/05/2208/08/2208/11/2209/03/2309/05/2309/08/2309/11/2327/02/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. PLRX Stock
  4. Calendar Pliant Therapeutics, Inc.